• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Phosphate (Glycophos) Injection

 Status: Currently in Shortage

 » Date first reported: 05/29/2013
 » Therapeutic Categories: Gastroenterology; Pediatric; Total Parenteral Nutrition

Fresenius Kabi USA, LLC (Reverified 09/11/2014)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Glycophos (sodium glycerophosphate) injection, 20 mL vial (NDC 63323-241-20) Importation began May 2013. Please check wholesalers for inventory and reference Glycophos. Currently backordered. Next release anticipated Q4 2014. Fresenius Kabi USA, LLC (FK USA) in conjunction with FDA has initiated temporary importation of Glycophos (sodium glycerophosphate) injection into the US market to address this shortage. Please see the Dear Healthcare Professional Letter (PDF - 443KB)20 for additional product and supply information. FK USA is releasing Glycophos to its authorized distributors. Shortage per Manufacturer: Increase in demand

Dear Healthcare Professional Letter

Other
-
-